Ramelta Tablet 8 mg is a prescription medication used to treat insomnia characterized by difficulty falling asleep. It is a melatonin receptor agonist that helps regulate the sleep-wake cycle by mimicking the effects of melatonin, a natural hormone that promotes sleep.
Ramelta Tablet 8 mg is primarily used for the treatment of insomnia, particularly for individuals who have difficulty falling asleep. It is prescribed for short-term management of sleep onset insomnia.
| Brand Name | Ramelta |
|---|---|
| Type | Tablet |
| Weight | 8 mg |
| Generic | Ramelteon |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Ramelta Tablet 8 mg works by selectively binding to and activating melatonin receptors (MT1 and MT2) in the brain. These receptors are involved in regulating the circadian rhythm and sleep-wake cycle. By stimulating these receptors, Ramelta Tablet 8 mg helps promote the onset of sleep and align the body’s internal clock with the desired sleep schedule.
Ramelta Tablet 8 mg typically begins to work within 30 to 60 minutes after administration. Peak plasma levels are reached within 1-2 hours, and its effects can be observed as soon as the first night of use. For optimal results, it should be taken about 30 minutes before bedtime.
Ramelta Tablet 8 mg is well-absorbed after oral administration. Its bioavailability is about 1.8%, largely due to first-pass metabolism in the liver. Food can affect its absorption, with a high-fat meal potentially increasing the time to reach peak plasma levels.
Ramelta Tablet 8 mg is primarily metabolized in the liver by cytochrome P450 enzymes (CYP1A2 and CYP2C19). Its metabolites are excreted through the urine. A small portion is also eliminated in the feces.
The usual recommended dosage of Ramelta Tablet 8 mg is 8 mg taken orally once daily, approximately 30 minutes before bedtime. The dosage should not exceed 8 mg per day. Dosage adjustments may be necessary for individuals with liver impairment.
Ramelta Tablet 8 mg is administered orally in tablet form. It should be swallowed whole with a glass of water and taken on an empty stomach to ensure optimal absorption. It should not be chewed or crushed.
Common side effects of Ramelta Tablet 8 mg may include:
Less common side effects may include allergic reactions, mood changes, or vivid dreams.
Ramelta Tablet 8 mg has a low potential for toxicity, but high doses may lead to increased sedation, dizziness, and confusion. In case of overdose, supportive measures should be taken, and medical attention should be sought if severe symptoms occur.
Precautions include:
Ramelta Tablet 8 mg may interact with other medications that affect CYP1A2 or CYP2C19 enzyme activity, such as:
These interactions may alter Ramelta Tablet 8 mg's effectiveness or increase the risk of side effects.
Ramelta Tablet 8 mg should be used with caution in patients with severe liver impairment, as it is metabolized primarily by the liver. Adjustments to dosage or frequency may be necessary.
Drug interactions that may affect Ramelta Tablet 8 mg include:
These interactions can impact the metabolism and efficacy of Ramelta Tablet 8 mg.
Consumption of high-fat meals can delay the absorption of Ramelta Tablet 8 mg and potentially affect its efficacy. It is recommended to take the medication on an empty stomach for optimal results.
Ramelta Tablet 8 mg should be used during pregnancy only if the potential benefits outweigh the risks. It is classified as a Category C drug, meaning that risk to the fetus cannot be ruled out. Consult a healthcare provider before use.
Ramelta Tablet 8 mg is excreted in breast milk in small amounts. The potential effects on a nursing infant are not well-studied. Consult a healthcare provider to weigh the benefits and risks of using Ramelta Tablet 8 mg while breastfeeding.
Acute overdose of Ramelta Tablet 8 mg may lead to excessive sedation, dizziness, and confusion. In case of overdose, supportive measures should be taken. Contact a healthcare provider or poison control center for guidance.
Ramelta Tablet 8 mg is contraindicated in patients with severe liver impairment, as it may significantly affect the drug's metabolism and increase the risk of adverse effects.
Ramelta Tablet 8 mg should be taken as directed by a healthcare provider. It is typically administered once daily, approximately 30 minutes before bedtime. Do not exceed the recommended dose and ensure the full course of treatment is completed if prescribed for short-term use.
Store Ramelta Tablet 8 mg tablets at room temperature, between 20-25°C (68-77°F). Keep the medication in a tightly closed container, away from moisture and heat. Do not use the medication after the expiration date.
The volume of distribution of Ramelta Tablet 8 mg is not widely documented, but it is distributed throughout the body after oral administration.
The elimination half-life of Ramelta Tablet 8 mg is approximately 1 to 2.6 hours. This short half-life contributes to its effective regulation of sleep onset without long-term sedation.
Ramelta Tablet 8 mg is cleared from the body primarily through liver metabolism, with its metabolites excreted in the urine. The clearance rate may be affected by liver function and drug interactions.
See in details version Ramelta Tablet 8 mg also Ramelta Tablet 8 mg in bangla